Press Releases

Mylan and Biocon Launch First Trastuzumab Biosimilar Ogivri in Australia

Biocon Ltd. and Mylan N.V. announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar to Herceptin®1 (trastuzumab), for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma). Ogivri is the first trastuzumab biosimilar...

JCDC the Research Arm of Jehangir Hospital Is the First Hospital in India to Join Clinerions Patient Network Explorer Platform

JCDC is the research arm of Jehangir Hospital, Pune, India. The hospital has over 350 beds, servicing patients throughout Pune and beyond. It has a wide range of disease-area specializations, including, but not limited to: cardiology, oncology, endocrinology, pediatrics,...

UPS gains GDP certification for pharma shipping in Germany

UPS announced that its services for pharmaceutical shipping in Germany are now Good Distribution Practice (GDP)-certified, meeting standards set by the European Union for the shipment of non-temperature controlled healthcare products for human use. With this certification granted by...

Signant Health Launches Partner Program to Team with CRO’s Committed to Improving Clinical Trials with Patient Centric Technology

Signant Health , a leading provider of technology for clinical research, launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient...

Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody

Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338...

Boston Analytical Continues Expansion with Office in Cambridge MA

Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes two years after opening a 30,000 square foot, state-of-the-art facility in Salem, NH, and one...

Pre-scored chip substrates provide new options for manufacturers of innovative diagnostic consumables

SCHOTT NEXTERION® PreScora will be featured at the American Association of Clinical Chemistry’s annual scientific meeting and clinical lab expo in Anaheim, Ca. Biotech companies have made remarkable strides developing lab-on-a-chip (LoaC) technology — ever smaller chips that integrate laboratory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read